Relationship between cytopenia and cytogenetic response in imatinib mesylate treated Ph-positive chronic myeloid leukemia in chronic phase patients

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Volumn 35, Issue 2, 2003, Pages 136-140

  Jiang, Qian ^a   Chen, Shanshan ^a   Jiang, Bin ^a   Jiang, Hao ^a   Lu, Ying ^a   Huang, Xiaojun ^a   Lu, Daopei ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

GENETICS; HUMAN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; ORAL DRUG ADMINISTRATION; PATHOLOGY; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BENZAMIDES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PYRIMIDINES; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 34147137991     PISSN: 1671167X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)